From cosmetics to clothing and mobile accessories, the promise of a cheap deal is hard to resist. But that bargain may come ...
Regular travellers on the Simtokha–Dochula highway can expect some relief soon. The stretch, which has deteriorated over the past few months, is expected ...
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or ...
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...
Four substudies did not meet pre-specified primary endpoints -- -- Post hoc analyses show setmelanotide achieved statistically significant BMI reductions in patients with obesity due to a heterozygous ...
Rhythm Pharmaceuticals’ phase 3 EMANATE trial of setmelanotide fails to meet primary endpoints: Boston Wednesday, March 18, 2026, 18:00 Hrs [IST] Rhythm Pharmaceuticals, Inc., a ...
Officials say a crescent moon, built by students to celebrate Ramadan, was found destroyed atop a Tempe mountain this week.
A look at 10 of the most stunning, museum-quality Porsches that defined Luft Tokyo’s unforgettable debut in Japan.
After about 30 minutes of setting up their “Bucket O’ Soldiers” on a dirt mound while camping in the Okanogan-Wenatchee ...
US auto safety regulators escalated an investigation of Tesla Inc.’s partially automated driving system marketed as “Full-Self Driving,” citing additional crashes pointing to potential flaws in the ...
Rhythm Pharmaceuticals (NASDAQ:RYTM) announced that the U.S. Food and Drug Administration has approved IMCIVREE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results